These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 17658508

  • 21. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y, Martinez V, Million M, Maillot C.
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Itomi Y, Tanaka T, Matsushita K, Kawamura T, Kojima T, Aso K, Matsumoto-Okano S, Tsukimi Y.
    Neurogastroenterol Motil; 2020 May; 32(5):e13795. PubMed ID: 31970891
    [Abstract] [Full Text] [Related]

  • 23. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C, Isobe Y, Kawamura R, Kiuchi Y, Tsuchida K, Higuchi S.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
    [Abstract] [Full Text] [Related]

  • 24. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC, Dong L, Wang Y, Wang SH, Cao MB.
    Chin Med J (Engl); 2007 Dec 05; 120(23):2069-74. PubMed ID: 18167178
    [Abstract] [Full Text] [Related]

  • 25. Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats.
    Verleye M, Gillardin JM.
    Physiol Behav; 2004 Oct 15; 82(5):891-7. PubMed ID: 15451655
    [Abstract] [Full Text] [Related]

  • 26. Electro-acupuncture attenuates stress-induced defecation in rats with chronic visceral hypersensitivity via serotonergic pathway.
    Tian XY, Bian ZX, Hu XG, Zhang XJ, Liu L, Zhang H.
    Brain Res; 2006 May 09; 1088(1):101-8. PubMed ID: 16650387
    [Abstract] [Full Text] [Related]

  • 27. Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats.
    Ohashi-Doi K, Gale JD, Kurebayashi Y.
    Eur J Pharmacol; 2010 Sep 15; 643(1):107-12. PubMed ID: 20598680
    [Abstract] [Full Text] [Related]

  • 28. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
    Matsueda K, Harasawa S, Hongo M, Hiwatashi N, Sasaki D.
    Scand J Gastroenterol; 2008 Sep 15; 43(10):1202-11. PubMed ID: 18618371
    [Abstract] [Full Text] [Related]

  • 29. 5-HT6 receptor antagonism reduces defecation in rat: A potential treatment strategy for irritable bowel syndrome with diarrhea.
    Hagsäter SM, Lisinski A, Eriksson E.
    Eur J Pharmacol; 2019 Dec 01; 864():172718. PubMed ID: 31586629
    [Abstract] [Full Text] [Related]

  • 30. Melatonin attenuates stress-induced defecation: lesson from a rat model of stress-induced gut dysfunction.
    Song GH, Gwee KA, Moochhala SM, Ho KY.
    Neurogastroenterol Motil; 2005 Oct 01; 17(5):744-50. PubMed ID: 16185314
    [Abstract] [Full Text] [Related]

  • 31. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H, Paragomi P, Paydar MJ, Moezi L, Bahadori M, Behfar B, Ardalan FA, Dehpour AR.
    J Gastroenterol Hepatol; 2009 Apr 01; 24(4):672-80. PubMed ID: 19032458
    [Abstract] [Full Text] [Related]

  • 32. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA.
    Neurogastroenterol Motil; 2005 Jun 01; 17(3):415-22. PubMed ID: 15916629
    [Abstract] [Full Text] [Related]

  • 33. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ.
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct 01; 13(3):461-71. PubMed ID: 10580922
    [Abstract] [Full Text] [Related]

  • 34. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
    Houghton LA, Foster JM, Whorwell PJ.
    Aliment Pharmacol Ther; 2000 Jun 01; 14(6):775-82. PubMed ID: 10848662
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.
    Neurogastroenterol Motil; 2011 Dec 01; 23(12):1098-104. PubMed ID: 21920001
    [Abstract] [Full Text] [Related]

  • 36. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats.
    Miyata K, Ito H, Fukudo S.
    Am J Physiol; 1998 May 01; 274(5):G827-31. PubMed ID: 9612262
    [Abstract] [Full Text] [Related]

  • 37. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors.
    Tada K, Kasamo K, Suzuki T, Matsuzaki Y, Kojima T.
    Hippocampus; 2004 May 01; 14(2):143-7. PubMed ID: 15098719
    [Abstract] [Full Text] [Related]

  • 38. Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5-hydroxytryptamine 3 receptor on gastrointestinal function.
    Kawano K, Mori T, Fu L, Ito T, Niisato T, Yoshida S, Shiokawa S, Sato Y, Murakami H, Shishikura T.
    Neurogastroenterol Motil; 2005 Apr 01; 17(2):290-301. PubMed ID: 15787949
    [Abstract] [Full Text] [Related]

  • 39. Cilansetron in the treatment of diarrhea-predominant irritable bowel syndrome?
    Stacher G.
    Expert Rev Gastroenterol Hepatol; 2007 Oct 01; 1(1):15-27. PubMed ID: 19072430
    [Abstract] [Full Text] [Related]

  • 40. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR, Luo JY, Shang L, Kong WM.
    Chin J Dig Dis; 2006 Oct 01; 7(2):89-96. PubMed ID: 16643336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.